Inclusion Body Myositis
📧 Sign up to get email alerts when something new happens for Inclusion Body Myositis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Environmental Risk Factors for Myositis in Military Personnel
A completed NIEHS-sponsored clinical study evaluated environmental risk factors for myositis in military personnel, including dermatomyositi…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Adult and Juvenile Myositis
This entry reports that a NIEHS-sponsored clinical trial investigating adult and juvenile myositis is currently recruiting for dermatomyosit…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: IBM Dietary Surveillance Study
This clinical trial update announces a study titled IBM Dietary Surveillance Study conducted by Manchester Metropolitan University. The tria…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies [NA]
A completed clinical trial evaluating the diagnostic accuracy of whole-body magnetic resonance imaging for detecting inflammatory myopathies…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease [NA]
A clinical trial is evaluating the effects of whole-body electrical muscle stimulation on adults with various neuromuscular diseases and is …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Sporadic Inclusion Body Myositis Natural History Study
A natural history study of sporadic inclusion body myositis and inclusion body myositis at the University of California, Irvine is currently…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis [Phase 2, Phase 3]
A completed Phase 2/3 study evaluating the efficacy and safety of ABC008 for inclusion body myositis.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
The MIHRA PRISMS clinical study for myositis is currently recruiting, sponsored by the Myositis International Health & Research Collaborativ…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Phase III Trial of Sirolimus in IBM [Phase 3]
Phase III trial of sirolimus in inclusion body myositis is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Inclusion Body Myositis Treatment With Celution Processed Adipose Derived Regenerative Cells [NA]
A clinical trial evaluating Celution-processed adipose-derived regenerative cells for Inclusion Body Myositis has completed.
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Ruxolitinib Treatment in Inclusion Body Myositis [Phase 2]
Phase 2 study evaluating ruxolitinib for inclusion body myositis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders
Development and validation of the FBIndex, a tool to assess falls risk in patients with various neuromuscular disorders.
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis [Phase 2, Phase 3]
Clinical trial comparing rapamycine to placebo for inclusion body myositis has completed (Phase 2/Phase 3); no efficacy results are provided…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Long-term Extension Study of Ulviprubart (ABC008) in Subjects With Inclusion Body Myositis [Phase 2, Phase 3]
This entry notes a long-term extension study of Ulviprubart (ABC008) in Inclusion Body Myositis, spanning Phase 2 and Phase 3, which is curr…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period. [NA]
This clinical trial update outlines a study evaluating whether assistive gait devices, following a training period, can reduce fall risk in …
-
CLINICAL_TRIALS other · 2025-07-04Clinical Trial Update: Monitoring Biomarker for Detecting Change in Physical Activity and Limb Function in Inclusion Body Myositis Over Time
A University of Kansas Medical Center-sponsored clinical trial is testing a biomarker to monitor changes in physical activity and limb funct…
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: Exercise as Treatment for Patients With Inclusion Body Myositis [NA]
A feasibility study assessing exercise as a treatment for Inclusion Body Myositis has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: A Phase 1 Study of ABC008 in Ascending (Single Ascending Dose/Multiple Ascending Dose) Study in Patients With (IBM) [Phase 1]
The Phase 1 SAD/MAD study of ABC008 in Inclusion Body Myositis has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Safety and Tolerability of Phenylbutyrate in Inclusion Body Myositis [Phase 1]
Phase 1 trial update reporting safety and tolerability data for phenylbutyrate in Inclusion Body Myositis, with the study status shown as co…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: The Risk of Falls Index for Patients With Neuromuscular Disorders
A completed trial evaluating a Falls Index to assess fall risk in patients with neuromuscular disorders, including Inclusion Body Myositis, …
-
CLINICAL_TRIALS trial_result · 2023-09-15Clinical Trial Update: Arimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension Trial [Phase 3]
Open-label extension phase 3 trial of arimoclomol in sporadic inclusion body myositis has terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: Study of Arimoclomol in Inclusion Body Myositis (IBM) [Phase 2]
Phase 2 clinical trial of arimoclomol in Inclusion Body Myositis has completed with results posted.
-
CLINICAL_TRIALS research · 2017-02-09Clinical Trial Update: Natalizumab in Inclusion Body Myositis (IBM) [Phase 1]
A Phase 1 clinical trial evaluating natalizumab for inclusion body myositis is ongoing, with the current status listed as unknown.
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Arimoclomol in Sporadic Inclusion Body Myositis [Phase 2, Phase 3]
This document reports an update on a Phase 2/3 trial of arimoclomol for sporadic Inclusion Body Myositis, with results posted in 2017.
-
CLINICAL_TRIALS research · 2015-09-01Clinical Trial Update: Natural History in CCFDN and IBM Syndromes
This completed observational study from Ludwig-Maximilians-University Munich examines the natural history of Congenital cataracts, facial dy…